EGFR is overexpressed in 30–89 % of cases of pancreatic ductal carcinoma.[65] Targeted therapy with nanoparticle conjugated with epidermal growth factor (EGF) ligand depicted increased cellular uptake mechanisms and apoptosis of targeted cells. The gene discussed is EGF; the disease is pancreatic ductal adenocarcinoma.